Atlas Trials

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Clinical trial NCT01605890 · COMPLETED

Trial details

NCT number
NCT01605890
Sponsor
ANRS, Emerging Infectious Diseases
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-2 Infection
Start date
2012-07-01
Primary completion
2015-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.